Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating AK111 for moderate to severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• AK111

Snippet

Sponsor: Akeso | Conditions: Psoriasis, Skin Diseases | Phase 3 | Status: COMPLETED